Coeptis Therapeutics Holdings, Inc. – OTC:COEP
Coeptis Therapeutics Holdings stock price today
$13.81
+13.62
+7479.58%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Coeptis Therapeutics Holdings stock price monthly change
-39.13%
month
Coeptis Therapeutics Holdings stock price quarterly change
-39.13%
quarter
Coeptis Therapeutics Holdings stock price yearly change
-76.36%
year
Coeptis Therapeutics Holdings key metrics
Market Cap | 27.89M |
Enterprise value | 46.47M |
P/E | -0.56 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 7.44 |
PEG ratio | 0.01 |
EPS | -0.56 |
Revenue | N/A |
EBITDA | -16.73M |
Income | -16.13M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCoeptis Therapeutics Holdings stock price history
Coeptis Therapeutics Holdings stock forecast
Coeptis Therapeutics Holdings financial statements
| Jun 2023 | 0 | -3.11M | |
|---|---|---|---|
| Sep 2023 | 0 | -6.26M | |
| Dec 2023 | 1.50M | -3.75M | -250.06% |
| Mar 2024 | 0 | -3.00M |
| 2027 | 0 | -4.62M |
|---|
Analysts Price target
Financials & Ratios estimates
| 2024-03-25 | -0.12 | -0.08 |
|---|
| Jun 2023 | 7155699 | 4.66M | 65.21% |
|---|---|---|---|
| Sep 2023 | 7170767 | 2.15M | 30.11% |
| Dec 2023 | 8071089 | 3.75M | 46.55% |
| Mar 2024 | 9394321 | 5.03M | 53.6% |
| Jun 2023 | -1.90M | -350K | 3.39M |
|---|---|---|---|
| Sep 2023 | -1.95M | 350K | -224.92K |
| Dec 2023 | -1.69M | 0 | 1.75M |
| Mar 2024 | -1.90M | -100K | 1.56M |
Coeptis Therapeutics Holdings alternative data
| Aug 2023 | 4 |
|---|---|
| Sep 2023 | 4 |
| Oct 2023 | 4 |
| Nov 2023 | 4 |
| Dec 2023 | 4 |
| Jan 2024 | 4 |
| Feb 2024 | 4 |
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 4 |
| Jun 2024 | 5 |
| Jul 2024 | 5 |
Coeptis Therapeutics Holdings other data
0.92%
-33.70%
of COEP is owned by hedge funds
131.38K
-3.64M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2021 | 0 | 1200000 |
-
What's the price of Coeptis Therapeutics Holdings stock today?
One share of Coeptis Therapeutics Holdings stock can currently be purchased for approximately $13.81.
-
When is Coeptis Therapeutics Holdings's next earnings date?
Unfortunately, Coeptis Therapeutics Holdings's (COEP) next earnings date is currently unknown.
-
Does Coeptis Therapeutics Holdings pay dividends?
No, Coeptis Therapeutics Holdings does not pay dividends.
-
How much money does Coeptis Therapeutics Holdings make?
Coeptis Therapeutics Holdings has a market capitalization of 27.89M. Coeptis Therapeutics Holdings made a loss 21.27M US dollars in net income (profit) last year or -$0.08 on an earnings per share basis.
-
What is Coeptis Therapeutics Holdings's stock symbol?
Coeptis Therapeutics Holdings, Inc. is traded on the OTC under the ticker symbol "COEP".
-
What is Coeptis Therapeutics Holdings's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Coeptis Therapeutics Holdings?
Shares of Coeptis Therapeutics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Coeptis Therapeutics Holdings have?
As Jul 2024, Coeptis Therapeutics Holdings employs 5 workers, which is 25% more then previous quarter.
-
When Coeptis Therapeutics Holdings went public?
Coeptis Therapeutics Holdings, Inc. is publicly traded company for more then 4 years since IPO on 8 Jan 2021.
-
What is Coeptis Therapeutics Holdings's official website?
The official website for Coeptis Therapeutics Holdings is coeptistx.com.
-
Where are Coeptis Therapeutics Holdings's headquarters?
Coeptis Therapeutics Holdings is headquartered at 105 Bradford Road, Wexford, PA.
-
How can i contact Coeptis Therapeutics Holdings?
Coeptis Therapeutics Holdings's mailing address is 105 Bradford Road, Wexford, PA and company can be reached via phone at +7 249346467.
Coeptis Therapeutics Holdings company profile:
Coeptis Therapeutics Holdings, Inc.
coeptistx.comExchange:
OTC
Full time employees:
4
Industry:
Biotechnology
Sector:
Healthcare
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors. and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
105 Bradford Road
Wexford, PA 15090
Wexford, PA 15090
CIK: 0001819663
ISIN: US19207C1045
CUSIP: 19207C104
